CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-01 | Hsieh Ming President and CEO | Grant or award | +30,000 | 30,000 | ||
| 2022-08-01 | POST LEONARD E Director | Grant or award | +8,000 | 8,000 | ||
| 2022-08-01 | Marsh Linda Director | Grant or award | +1,600 | 5,600 | ||
| 2022-08-01 | BOLGER JOHN C Director | Grant or award | +1,600 | 5,100 | ||
| 2022-08-01 | Xie Jian President and COO | Shares withheld for taxes | −872 | $59.54 | $52K | 318,161 |
| 2022-07-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −87 | $59.75 | $5K | 855,650 |
| 2022-06-08 | Hsieh Ming President and CEO | Other acquisition · Forward sale contract (obligation to sell) | +1,000,000 | 1,000,000 | ||
| 2022-06-02 | KIM PAUL CFO and Treasurer | Sale | −415 | $55.10 | $23K | 153,162 |
| 2022-05-31 | Xie Jian President and COO | Sale | −668 | $54.54 | $36K | 319,033 |
| 2022-05-31 | BOLGER JOHN C Director | Option exercise | +313 | $3.93 | $1K | 4,313 |
| 2022-05-31 | BOLGER JOHN C Director | Sale | −313 | $55.32 | $17K | 4,000 |
| 2022-05-31 | BOLGER JOHN C Director | Option exercise | +313 | $5.81 | $2K | 4,313 |
| 2022-05-31 | BOLGER JOHN C Director | Sale | −313 | $55.44 | $17K | 4,000 |
| 2022-05-31 | BOLGER JOHN C Director | Sale | −500 | $55.25 | $28K | 3,500 |
| 2022-05-31 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −313 | 0 | ||
| 2022-05-31 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −313 | 1,250 | ||
| 2022-05-19 | Xie Jian President and COO | Sale | −10,000 | $58.29 | $583K | 319,701 |
| 2022-05-18 | Yen Yun Director | Grant or award | +2,000 | 2,000 | ||
| 2022-05-18 | Marsh Linda Director | Grant or award | +2,000 | 4,000 | ||
| 2022-05-18 | BOLGER JOHN C Director | Grant or award | +2,000 | 4,000 |
Page 19 of 23 · 453 trades